Health News Summary: Cervical Cancer Vaccine, Angioplasty Risk, Oral Cancer, Diabetic Women and Birth Defects

September 7th, 2005 A simple ten minute survey to determine your life expectancy. It says about me: In an extremely high risk overweight category, meaning you are at extremely high risk for obesity-related illnesses such as heart disease, high blood pressure, stroke and cancer.

August 30th, 2005 European scientists collide head-on with diametrically opposite views on health risk with mobile usage.

February 27th, 2007 DCA has generated quite an interest in patients with Cancer, many even contemplating self-treatment for cure. The key points we know about DCA so far are: 1.

July 21st, 2005 One-day treatment with the anticancer drug carboplatin is as effective and less toxic than three weeks radiation therapy for a type of testicular cancer, according to a report published in this week's issue of The Lancet. For the last 50 years standard care for stage 1 seminoma - a cancer of the testes - has been surgical removal of the cancerous testicle (hemi-castration) followed by three weeks radiotherapy.

November 8th, 2007 Now this is something for religious bigots, who oppose embryonic stem cell research on ethical grounds (logically unsustainable but when have bigots listened to logic?), to chew upon. Latest research on cancer indicates that the dominant mechanism of cancer cells is to behave like early embryonic stem cells.

February 3rd, 2007 Investigators at the University of Alberta have recently reported that the drug DCA is able to cause tumor regression in a number of human cancers growing in animals. The drug, dichloroacetate (DCA), is being used for years to treat rare metabolic disorders and is known to be relatively safe.

April 20th, 2005 Report from the 4th World Congress on Prevention of Diabetes and its Complications, organised by the World Health Organization and others.

April 1st, 2005 The biocavity laser can show scientists the inner workings of a single cell. Paul Gourley and his colleagues at Sandia proved the laser could do that by studying cancer cells.

August 9th, 2005 Taking a daily 10 to 15 minute walk in the sun not only clears your head, relieves stress and increases circulation – it could also cut your risk of breast cancer in half according to Esther John, an epidemiologist at the Northern California Cancer Center. A study found that sunlight exposure lowered the risk of breast cancer by 30 to 40 percent.

July 7th, 2005 Speedel announced today the start of its Phase III study for SPP301, its once-a-day oral endothelin A receptor antagonist (ERA) in the indication of diabetic nephropathy (diabetic kidney disease). The ASCEND(1) study has begun with the first patient visit as per the schedule outlined by Speedel in March 2005 when the company reported successful completion of the Phase II clinical trials.

February 5th, 2007 India is the ideal place to conduct human trial for the effectiveness of DCA ( dichloroacetate ) as anti-cancer drug. The government regulations for human trial aren't as stringest as USA, there are funds available for such studies and frankly you don't need much.

July 17th, 2006 Scientists of the Indian Council of Agricultural Research (ICAR) have succeeded in developing an indigenous vaccine against bird flu (H5N1 virus). This feat has been achieved by scientists working at the Bhopal-based High Security Animal Disease Laboratory (HSADL) in a record time of four months under a Rs 8-crore project.

August 9th, 2005 Study conducted by researchers at the University of Scranton suggests that tea might prevent diabetes and its associated complications, including diabetic cataracts. Researchers led by Joe Vinson fed green and black tea to diabetic rats for three months and then monitored the chemical composition of the rats' blood and eye lenses.

April 14th, 2005 Researchers at Rice University in Texas have developed a new approach to fighting cancer, based on nanoscale particles that can both detect and destroy cancerous cells. The report appears in the April 13 issue of the American Chemical Society's journal Nano Letters.

September 27th, 2005 Pfizer Inc. said U.S. regulators (FDA) have approved its cholesterol lowering drug Lipitor. Lipitor is used to reduce the risk of stroke and heart attack in diabetic patients.